One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy

One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy

Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular degeneration characterised by an abnormal branching vascular network with aneurysmal polypoidal choroidal vascular lesions. PCV is more prevalent in Asian populations than in Caucasians, which may explain its und...

Full description

Bibliographic Details
Main Authors: Marta Medina-Baena, María Jesús Huertos-Carrillo, Laura Rodríguez, Juan Ignacio García-Pulido, Carlos Cornejo-Castillo, José María Calandria-Amiguetti
Format: Article
Language:English
Published: Karger Publishers 2018-03-01
Series:Case Reports in Ophthalmology
Subjects:
Aflibercept
Polypoidal choroidal vasculopathy
Polypoidal lesion
Combination therapy
Photodynamic therapy
Online Access:https://www.karger.com/Article/FullText/487227

Internet

https://www.karger.com/Article/FullText/487227

Similar Items